The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


Published online June 19, 2009
The Journal of Immunology, 2009, 183, 1253 -1262
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900570

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0900570v1
183/2/1253    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Frey, K. G.
Right arrow Articles by Bigley, N. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frey, K. G.
Right arrow Articles by Bigley, N. J.

HSV-1-Induced SOCS-1 Expression in Keratinocytes: Use of a SOCS-1 Antagonist to Block a Novel Mechanism of Viral Immune Evasion1

Kenneth G. Frey*, Chulbul M. I. Ahmed{ddagger}, Rea Dabelic{ddagger}, Lindsey D. Jager{ddagger}, Ezra N. Noon-Song{ddagger}, S. Mohammad Haider{ddagger}, Howard M. Johnson{ddagger} and Nancy J. Bigley2,*,{dagger}

* Department of Neuroscience, Cell Biology, and Physiology and {dagger} Department of Pathology, Wright State University, Dayton, OH 45435; and {ddagger} Department of Microbiology and Cell Science, University of Florida, Gainesville, FL 32611

Keratinocytes are important for the acute phase of HSV-1 infection and subsequent persistence in sensory nervous tissue. In this study, we showed that keratinocytes (HEL-30) were refractory to IFN-{gamma} induction of an antiviral state to HSV-1 infection, while IFN-{gamma} did induce an antiviral state in fibroblasts (L929). This led us to examine the possible role of suppressor of cytokine signaling-1 (SOCS-1) in this refractiveness. RT-PCR analysis of SOCS-1 mRNA expression in HSV-1-infected cells showed a 4-fold increase for keratinocytes while having a negligible effect on fibroblasts. A similar pattern was observed at the level of SOCS-1 protein induction. Activation of STAT1{alpha} in keratinocytes was inhibited by HSV-1 infection. A direct effect of HSV-1 on the SOCS-1 promoter was shown in a luciferase reporter gene assay. We have developed a small peptide antagonist of SOCS-1, pJAK2(1001–1013), that had both an antiviral effect in keratinocytes against HSV-1 as well as a synergistic effect on IFN-{gamma} induction of an antiviral state. HSV-1 ICP0 mutant was inhibited by IFN-{gamma} in HEL-30 cells and was less effective than wild-type virus in induction of SOCS-1 promoter. We conclude that SOCS-1 plays an important role in the inhibition of the antiviral effect of IFN-{gamma} in keratinocytes infected with HSV-1. The use of SOCS-1 antagonist to abrogate this refractiveness could have a transformational effect on therapy against viral infections.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the National Institutes of Health Grants 5R01NS51245 and 2R01AI056152 (to H.M.J.), Wright State University Research Foundation, Cellular Immunology Fund 550527 (to N.J.B.), and Sigma Xi Grant in Aid of Research (to K.G.F.).

2 Address correspondence and reprint requests to Dr. Nancy J. Bigley, Department of Neuroscience, Cell Biology, and Physiology and Department of Pathology, Wright State University, Dayton, OH 45435. E-mail address: nancy.bigley{at}wright.edu

3 Abbreviations used in this paper: SOCS, suppressor of cytokine signaling; CPE, cytopathic effect; KIR, kinase inhibitory region; moi, multiplicity of infection; siRNA, small interfering RNA; Tkip, tyrosine kinase inhibitor peptide.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.